Non-initiation of adjuvant hormonal therapy in women with hormone receptor positive breast cancer: The Breast Cancer Quality of Care Study (B-QUAL)

BACKGROUND: Adjuvant hormonal therapy for non-metastatic hormone receptor (HR)-positive breast cancer decreases risk of breast cancer recurrence and increases survival. However, some women do not initiate this life-saving treatment. METHODS: We used a prospective cohort design to investigate factors...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Neugut, Alfred I., Hillyer, Grace Clarke, Kushi, Lawrence H., Lamerato, Lois, Leoce, Nicole, Nathanson, S. David, Ambrosone, Christine B., Bovbjerg, Dana H., Mandelblatt, Jeanne S., Magai, Carol, Tsai, Wei-Yann, Jacobson, Judith S., Hershman, Dawn L.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3561459/
https://ncbi.nlm.nih.gov/pubmed/22527111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2066-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars